Elizabeth Cha assumed her position as country manager for Insilico Taiwan in January 2018. She is focusing her research interests in the areas of Alzheimer’s disease, dementia and anti-ageing by applying artificial intelligence in drug discovery and biomarker development. Her mission is to extend healthy longevity through innovative AI solutions.

In 2016 and 2017 Ms Cha worked in the executive office for the 2017 World Congress on Information Technology. From 2011 to 2016, when she worked for the Institute for Information Industry, her research focused on the semantic web, overall country economic analysis, industrial business model development and transnational project management to bridge the digital divide.

Ms Cha received her PhD degree from the University of Louisville, Kentucky, US, in 2008. Her research focus was computational analysis of expressed sequence tags for understanding gene regulation.

Health, Healthcare, Futurism, Alzheimers, Alzheimer's Disease, Aging, Artificial Intelligence Innovation,